VIRTUAL: Adeno-associated Virus Gene Therapy for Hereditary Neurologic Disorders

Time: 8:15 am
day: Day One

Details:

  • Exploring the vectors used to target hereditary neurologic disorders
  • Assessing the delivery methods and challenges for AAV; where does my vector go?
  • Evaluating gene therapy for CLN2 disease and APOE4 Alzheimer’s disease

Speakers: